Bank of New York Mellon Corp decreased its stake in shares of Acorda Therapeutics Inc (NASDAQ:ACOR) by 2.2% during the first quarter, according to the company in its most recent disclosure with the SE
Hetero's generic version of Remdesivir will be marketed under the brand name 'Covifor' in India. The drug will be priced at around Rs 5,000 per dose.

Hetero gets DCGI nod to launch COVID-19 drug

12:45pm, Sunday, 21'st Jun 2020
Domestic pharma firm Glenmark Pharmaceuticals had on Saturday launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price

Hetero gets DCGI nod to launch COVID-19 drug

11:06am, Sunday, 21'st Jun 2020
Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.The company has received the manufacturin
MOSCOW (NYTIMES) - When you enter a home in Moscow, you take off your shoes. When you go to a play, you have to check your coat. When you eat a burger, you often wear gloves.. Read more at straitstime
Federated Hermes Inc. raised its holdings in Acorda Therapeutics Inc (NASDAQ:ACOR) by 36.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (S
Pharma major Dr Reddy's Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market.
Cadila has also been working on a DNA vaccine to fight Covid-19, which is currently in the animal testing stage
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya capsules, 0
The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA
Drug major Glenmark Pharmaceuticals on Friday said it has received final nod from the health regulator for Fingolimod capsules.

Finally, WHO stops chloroquine trial - TheCable

12:11pm, Thursday, 18'th Jun 2020
The World Health Organisation (WHO) says it is stopping hydroxychloroquine solidarity trial for the treatment of COVID-19 patients. This comes three days after the United States Food and Drug Admini
Massachusetts Financial Services Co. MA raised its stake in shares of Acorda Therapeutics Inc (NASDAQ:ACOR) by 18.8% during the 1st quarter, according to the company in its most recent Form 13F filing
The FDA has identified four manufacturers labeled as homeopaths that are distributing dangerous injectable drugs.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE